Articles Dr Mina on the Evolution of T-DM1 and T-DXd in HER2+ Breast Cancer Lida A. Mina, MD May 18th 2023 Lida A. Mina, MD, discusses the evolution of the antibody-drug conjugates fam-trastuzumab deruxtecan-nxki and ado-trastuzumab emtansine in HER2-positive breast cancer. Read More...